Eyedetec Medical, Inc.Eyedetec Medical, Inc.Eyedetec Medical, Inc.Eyedetec Medical, Inc.Eyedetec Medical ensures a unique continuum of care for dry-eye patients
Natural mechanism, essential for ocular surface health
Dry eye symptoms and other internal symptoms
A recent Gartner poll showed that 48% of employees will likely work remotely at least part of the time after COVID-19 versus 30% before the pandemic.
https://www.gartner.com/smarterwithgartner/9-future-of-work-trends-post-covid-19/
One of the most common conditions leading patients to see an eye doctor 1
On patients and society, projected to be $7.8B by 2025 2
Persistent Pain, Tearing, Contact Lens Failure, Impaired Vision
Global increase among all age groups3
No Cure at Present Available
1 Clin Ophthalmol. 2/19; 13: 225–232
2 Transparency Market Research, 1/18
3 AARP report, 11/15
Pre-op ocular surface critical to outcomes
30% of patients stop using contacts due to dry eye
Dry Eye increases with age 25% of population > 50 yrs
Increased screen time leads to decrease frequency of blinking
30m patients in US - 350M WORLDWIDE GROWING ~ 7% ANNUALLY
https://www.clspectrum.com/issues/2020/january-2020/the-role-of-the-ocular-surface-in-contact-lens-wea
https://collaborativeeye.com/articles/best-of-aoc/osd-and-cataract-preparing-for-better-surgical-outcomes/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738658/ and https://www.uptodate.com/contents/dry-eye-disease.
https://www.independent.co.uk/life-style/health-and-families/smartphone-use-using-risk-of-dry-eye-disease-mobile-phone-social-media-facebook-optical-health-a7513051.html
Patented Resonant Frequency Stimulation™ (RFS) with Warming, induces
Liquefaction & Mobilization of Meibum (oil)
30+ years in ophthalmology as a practitioner and executive - Permanente Medical Group, Promedix, SpecialtyMD, Ventro, ConforMIS (NASDAQ: CFMS), Imaging Therapeutics, Clarity Medical Systems
Former CEO, Chairman and Board of Directors roles in global Ophthalmic Global Ophthalmic businesses
Senior Executive roles at Mynosys, HOYA Surgical Optics, Bausch+ Lomb, Allergan Medical Optics
30+ years in ophthalmic devices; respected marketing expert, author and speaker in global ophthalmology community
Deep experience in product positioning, value proposition refinement and brand building
30+ years in financial services - Executive positions: Merrill Lynch, Shearson Lehman, Salomon Brothers, Montgomery Securities, and BioAsia Investments LLC
25 years in R&D with focus on thermal engineering
Executive positions: National Renewable Energy Laboratory, TDA Research
20+ years in QA/RA - medical device, drug-device combination, robotics and implantable
Boston Scientific, Affymetrix, Invuity, Stryker, Nektar Therapeutics, Hansen Medical, Hologic
30+ years in quality engineering and manufacturing
McDonald Aircraft Corp., HON Industries, U.S. Navy Civil Engineer Corps, General Foods Corp, and Motorola